Siemens Announces FDA Clearance of Mammomat Fusion Mammography System

Sep 17, 2015

· New full-field digital mammography system addresses specific needs of the midrange price segment, including small to medium-sized hospitals

 

Siemens Healthcare has announced that the Food and Drug Administration (FDA) recently cleared the Mammomat Fusion – the latest addition to the Siemens family of full-field digital mammography systems that offers premium product features to address the specific needs of volume screening centers and small to medium-sized hospitals.

 

The Mammomat Fusion mammography system features a new generation cesium-iodide detector – an innovative, layered configuration of the photo diodes within the detector that enables more efficient utilization of the radiation dose. The result: high image quality at a patient dose that is at or below the range of other full-field digital mammography systems, with an even lower dose delivered in cases where the patient’s breast thickness exceeds 50 mm. And the system’s large image matrix of 23x30 cm makes the Mammomat Fusion the right choice for screening various breast sizes.

 

Patient-optimized dose

In addition to its new cesium-iodide detector, the Mammomat Fusion mammography system features selected technologies developed for Siemens’ premium Mammomat Inspiration platform. The OpDose feature ensures that the radiation dose can be tailored for each patient without compromising image quality. The technologist can select the appropriate parameters in accordance with the patient’s breast size and density. The screening process is also simplified for clinical staff thanks to the compact, syngo-based Acquisition Workstation (AWS). Users can load patient data directly from the radiology information system without requiring a second workstation. Clinical personnel also benefit from an intuitive, automated workflow. The system is ready for scanning with just one click, and manual positioning is extremely easy – so technologists can spend more time on the patient.

 

“With the introduction of the competitively priced Mammomat Fusion full-field digital mammography system, Siemens proudly enables more breast centers and smaller hospitals to offer women many of the same cutting-edge technological features previously found only on our premium breast imaging systems,” says Martin Silverman, Vice President of X-ray Products at Siemens Healthcare North America.

 

 

Contact for journalists:

Jeff Bell
Siemens Healthcare
Phone: 610-448-6348; E-mail: jeffrey.t.bell@siemens.com
Follow us on Twitter at: www.twitter.com/siemenshealth

 

 

Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 357,000 employees worldwide. Further information is available on the Internet at http://www.siemens.com.